When David Christie paid a visit to his son and daughter-in-law in Sussex two years ago, he had a far more exciting trip than usual. The 78-year-old had begun to suffer from periods of low mood.
London is one of the latest Canadian cities to host pioneering research into the potential of psychedelic drugs to treat severe mental illness. A Health Canada-approved clinical trial is seeking ...
Depression, affecting over 264 million people globally, presents significant treatment challenges, often due to the limited efficacy and adverse effects of traditional antidepressants and the ...
Imagine a severely depressed woman—let’s call her Amber—who just arrived at her therapist’s office. She is curious about receiving her first dose of psilocybin in a Phase 3 clinical study.
Psilocybin, commonly known as magic mushrooms, has shown promise in treating anorexia in early studies, mostly in rats. But ...
There has been a resurgence of interest in the use of psychedelics or consciousness altering substances such as psilocybin – the active ingredient in “magic mushrooms” to treat depression.
Melbourne: Anorexia nervosa is a severe mental health disorder where people fear weight gain. Those with the disorder have distorted body image and hold rigid beliefs their body is too big.